SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-238952
Filing Date
2019-09-05
Accepted
2019-09-05 17:07:09
Documents
12
Period of Report
2019-09-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d802698d8k.htm   iXBRL 8-K 27462
  Complete submission text file 0001193125-19-238952.txt   153323

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA once-20190905.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE once-20190905_lab.xml EX-101.LAB 18907
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE once-20190905_pre.xml EX-101.PRE 11860
10 EXTRACTED XBRL INSTANCE DOCUMENT d802698d8k_htm.xml XML 3477
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36819 | Film No.: 191077885
SIC: 2836 Biological Products, (No Diagnostic Substances)